Recombinant multi-species TCF3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TCF3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the E protein (class I) family of helix-loop-helix transcription factors. E proteins activate transcription by binding to regulatory E-box sequences on target genes as heterodimers or homodimers, and are inhibited by heterodimerization with inhibitor of DNA-binding (class IV) helix-loop-helix proteins. E proteins play a critical role in lymphopoiesis, and the encoded protein is required for B and T lymphocyte development. Deletion of this gene or diminished activity of the encoded protein may play a role in lymphoid malignancies. This gene is also involved in several chromosomal translocations that are associated with lymphoid malignancies including pre-B-cell acute lymphoblastic leukemia (t(1;19), with PBX1), childhood leukemia (t(19;19), with TFPT) and acute leukemia (t(12;19), with ZNF384). Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the short arm of chromosome 9. [provided by RefSeq, Sep 2011]
The Alternative Names of target: A1,AGM8,AGM8A,AGM8B,ALF2,Class B basic helix-loop-helix protein 21 (bHLHb21),E12,E12/E47,E2A,E47,ITF1,Immunoglobulin enhancer-binding factor E12/E47,Immunoglobulin transcription factor 1,KA1,Kappa-E2-binding factor,ME2,Pan1,Pan2,TCF-3,TCF3,Tcf3,Tcfe2a,Transcription factor 3 (TCF-3),Transcription factor E2-alpha,Transcription factor ITF-1,VDIR,bHLHb21,p75
Go
to TCF3 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T95715-Ag-1/ GM-Tg-hg-T95715-Ag-2 | Human TCF3 protein | Human |
GM-Tg-rg-T95715-Ag-1/ GM-Tg-rg-T95715-Ag-2 | Rat TCF3 protein | Rat |
GM-Tg-mg-T95715-Ag-1/ GM-Tg-mg-T95715-Ag-2 | Mouse TCF3 protein | Mouse |
GM-Tg-cynog-T95715-Ag-1/ GM-Tg-cynog-T95715-Ag-2 | Cynomolgus/Rhesus macaque TCF3 protein | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T95715-Ag-1/ GM-Tg-felg-T95715-Ag-2 | Feline TCF3 protein | Feline |
GM-Tg-cang-T95715-Ag-1/ GM-Tg-cang-T95715-Ag-2 | Canine TCF3 protein | Canine |
GM-Tg-bovg-T95715-Ag-1/ GM-Tg-bovg-T95715-Ag-2 | Bovine TCF3 protein | Bovine |
GM-Tg-equg-T95715-Ag-1/ GM-Tg-equg-T95715-Ag-2 | Equine TCF3 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-T95715-Ag-1/ GM-Tg-hg-T95715-Ag-2;
GM-Tg-rg-T95715-Ag-1/ GM-Tg-rg-T95715-Ag-2;
GM-Tg-mg-T95715-Ag-1/ GM-Tg-mg-T95715-Ag-2; GM-Tg-cynog-T95715-Ag-1/ GM-Tg-cynog-T95715-Ag-2; GM-Tg-felg-T95715-Ag-1/ GM-Tg-felg-T95715-Ag-2; GM-Tg-cang-T95715-Ag-1/ GM-Tg-cang-T95715-Ag-2; GM-Tg-bovg-T95715-Ag-1/ GM-Tg-bovg-T95715-Ag-2; GM-Tg-equg-T95715-Ag-1/ GM-Tg-equg-T95715-Ag-2 |
Products Name | TCF3 protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | TCF3 |
Protein Sub-location | Introcelluar Protein |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TCF3 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.